Skip to main content
Premium Trial:

Request an Annual Quote

Biolog Wins $2.5M Phase II NIH SBIR Grant to Develop Tox Applications for Cell Arrays

NEW YORK, Oct. 13 (GenomeWeb News) - Biolog has won a $2.5 million phase II SBIR grant from the NIH to further develop its cellular microarray technology, the Hayward, Calif.-based company said today.


Specifically, the company plans to develop cell-based assays for toxicology testing, based on its Phenotype MicroArray assay platform.


Under the phase I portion of the grant, Biolog has already developed a number of cell assays for use with human and mouse cell lines.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.